24 years' experience in accelerating transformational therapies as Senior Global Program Lead for Takeda Rare Diseases, as well as Takeda respiratory, immunology and neuroscience programs. Recent experience as CDO at Izana Bioscience and Program Lead supporting UK Vaccine Task Force and UK Antiviral Task Forces. Comprehensive development experience at Novartis in Respiratory and Immunology from preclinical research leadership to Senior Global Programme Director leading the creation, approval and execution of integrated project plans for both Seebri Breezhaler® and Ultibro Breezhaler® through development to launch in COPD.